• Wed, January 3, 2018
  • Thu, January 4, 2018
  • Tue, January 2, 2018

David Lewis Upgraded (ABT) to Buy on, Jan 2nd, 2018

David Lewis of Morgan Stanley, Upgraded "Abbott Laboratories" (ABT) to Buy on, Jan 2nd, 2018.

David has made no other calls on ABT in the last 4 months.



There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Citigroup" Maintained at Hold with Increased Target to $59 on, Thursday, October 19th, 2017


These are the ratings of the 2 analyists that currently disagree with David


  • Joanne Wuensch of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $65 on, Tuesday, December 12th, 2017
  • Matthew Taylor of "Barclays" Maintained at Buy with Increased Target to $64 on, Thursday, October 19th, 2017